Functional properties of the human ventral mesencephalic neural stem cell line hVM1. by Tonnesen, Jan et al.
Functional properties of the human ventral mesencephalic neural stem cell line hVMl 
Jan Tonnesen a,1) Emma Gonzalez Seiz b,1) Milagros Ramos b, Olle Lindvallc, 
Alberto Martinez-Serrano b, Merab Kokaia a'* 
a
 Experimental Epilepsy Group, Wallenberg Neuroscience Center, Lund University Hospital, 22Í 84, Lund, Sweden 
b
 Laboratory of Human Neural Stem Cell Biology, Department of Molecular Biology and Center of Molecular Biology Severo Ochoa, UA.M.-CS.LC Campus Cantoblanco, Madrid, Spain 
c
 Laboratory of Neurogenesis and Cell Therapy, Wallenberg Neuroscience Center, Lund University Hospital, 22Í 84, Lund, Sweden 
A B S T R A C T 
The human fetal ventral mesencephalon-derived stem cell line, hVTVIl, yields high number of tyrosine 
hydroxylase-expressing presumed dopaminergic neurons upon in vitro differentiation. Here we report that 
cells generated from this line differentiate into a neuronal phenotype, express electrophysiological 
properties of functional neurons and respond to neurotransmitters in vitro. However, the electrophysiolo-
gical properties are immature and the cells require longer maturation time than possible under in vitro 
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Clinical trials with intrastriatal transplantation of human fetal 
mesencephalic tissue in patients with Parkinson's disease (PD) have 
provided proof-of-principle that grafted dopaminergic neurons can 
reinnervate the denervated striatum, release dopamine, become 
functionally integrated in host neural circuitries, and in some cases 
give rise to substantial clinical improvement (Lindvall and Bjorklund, 
2004). The quest for a stem cell source has been ongoing ever since in 
order to provide sufficient quantities of standardized, transplantable 
dopaminergic neurons to implement clinically competitive cell 
replacement therapy for PD. Immortalized human neural stem cell 
lines are suitable model systems for studying genetic and epigenetic 
influences on stability over passages, and on stem cell proliferation and 
differentiation in vitro and in vivo. Their advantage is multipotency 
within the neural lineage, expandability and stability, making them 
available over practically indefinite periods of time (Martinez-Serrano 
et al., 2001; Villa et al., 2002, 2004; Kim, 2007). Several studies have 
described amelioration of behavioral deficits by grafting such 
immortalized human stem cells in rodent models of neurological 
disease (Lee et al., 2007), and have characterized their immunocyto-
chemical and biochemical features. However, few studies have 
addressed the functional properties of human neural stem cell lines 
(Jung et al., 1998; Cho et al., 2002; Lotharius et al., 2002; De Filippis et 
al., 2007; Donato et al., 2007), most of them failing to demonstrate 
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maturation of these cells into neurons that can generate full-blown 
action potentials (Jung et al., 1998; Cho et al., 2002; De Filippis et al., 
2007; Donato etal., 2007). 
We recently reported on a newly derived human fetal ventral 
mesencephalic stem cell line, hVMl, that generates high fractions of 
dopaminergic cells, even after considerable expansion (>10 passages) 
(Villa et al., 2009). The hVMl cell line was subjected to thorough 
biochemical, genetic, and immunocytochemical characterization to 
document its usefulness as a model for developing clinically 
competent cell lines for PD (Villa et al., 2009). Here we have explored 
the functional properties of hVMl cells in vitro, based on calcium 
imaging and electrophysiological investigations. Interestingly, using 
electrophysiological whole-cell patch-clamp measurements, we 
found neuronal properties in more than half of all recorded cells, 
including immature action potentials and membrane rectification. We 
observed generation of mature spontaneous action potentials in one 
cell. Calcium imaging demonstrated that hVMl cells, which have 
differentiated to neurons, are responsive to glutamate, dopamine and 
GABA, as expected for ventral mesencephalic neurons. 
The derivation of the hVMl cell line was previously described in 
detail (Villa et al., 2009). Briefly, cells were isolated from the ventral 
mesencephalic region of a dead, aborted human fetus, aged 10 weeks, 
at Lund University Hospital, according to guidelines approved by the 
Lund/Malmó Ethical Committee. Cells were immortalized by infection 
with a retroviral vector coding for v-myc (LTR-vmyc-SV40p-Neo-LTR) 
(Villa et al., 2000) generating the hVMl polyclonal cell line (Villa et al., 
2009). 
Cells were expanded as attached cultures on poly-L-lysine (PLL, 
10 ug/ml)-coated dishes in N2 supplemented DMEM/F12 medium in 
the presence of 20 ng/ml of each of EGF and bFGF (Villa et al., 2009). 
To induce differentiation of the cells, bFGF and EGF were withdrawn 
from the medium and human recombinant glial cell line-derived 
neurotrophic factor (GDNF, 2 ng/ml, Peprotech) and dibutyryl-cAMP 
(1 uM, Sigma) were added (Lotharius et al., 2002; Riaz et al., 2002). 
After plating on PLL-coated glass coverslips for differentiation (105 
cells/cm2), cells were kept in proliferation medium for 24 h before 
changing to differentiation medium. All culturing was done at 37 °C 
and 95% humidity in a low oxygen atmosphere (5% 02, 5% C02). For all 
experiments, we used hVMl cell line at passage 11 to 12. 
For immunocytochemical analysis, 4% PFA-fixed samples were 
incubated overnight with primary antibodies against: (3-III-tubulin 
(1:1000, monoclonal, Sigma), Glial Fibrillary Acidic Protein (GFAP; 
1:1000, monoclonal, Sigma) and tyrosine hydroxylase (TH; 1:1000, 
polyclonal, Chemicon). Cells were then incubated with the secondary 
antibody for 30 min. Cell nuclei were counterstained with To-Pro 
(1:500; Invitrogen). Specificities of secondary antibodies were 
confirmed by parallel immunostainings without the primary antibody. 
For calcium imaging experiments, cells were loaded with 10 uM 
Fura-2 AM (Molecular Probes) for 30 min at 37 °C in HBSS medium 
added 5.55 mM glucose and 0.02% Pluronic F-127 (Molecular Probes), 
and washed for 20 min in HBSS medium. Next, coverslips were 
mounted in a perfusion chamber on the microscope stage at 37 °C as 
described in Ruiz et al. (1998). Single cell analysis of the changes in 
cytosolic calcium concentration ([Ca2+]¡) was expressed as the ratio of 
Fura-2 fluorescence intensity at 340 and 380 nm excitation. Different 
neurotransmitters and potassium were added as a bolus at the 
indicated times and at the following concentrations (arrows in Figs. 
ID, G, L): 100 uM dopamine (Sigma); 100 uM -y-aminobutyric acid 
(GABA, Tocris Cookson); 100 uM glutamate (Sigma). The concentra-
tions of drugs and potassium are within the range previously reported 
to elicit cytosolic calcium release in calcium imaging experiments 
(Jung et al., 1998; Malmersjo et al., 2009). Cells were washed with Mg-
free HBSS medium and supplemented with 30 uM of glycine just prior 
to the addition of glutamate. Two selective receptor antagonists were 
used: 5-methyl-10,ll-dihydro-5-dibenzocyclohepten-5,10-imine 
maléate (MK-801; 50 uM; Tocris Cookson) for blocking glutamate 
receptors (NMDA subtype) and picrotoxin (PTX; 100 uM; Tocris 
Cookson) for blocking GABAA receptors. For KCl-induced depolariza-
tion of cells, the recording chamber was perfused with an isosmotic 
HBSS solution containing 60 mM KC1 (Supplementary figure 1). 
Functional properties of differentiated stem cells were evaluated 
by the whole-cell patch-clamp technique as described previously 
(Parish, Castelo-Branco et al. 2008). In short, coverslips with 
differentiated cells were transferred to a recording chamber contin-
uously perfused at a rate of 3 ml/min, at room temperature, with 
carbogenated (95% 02/5% C02) artificial cerebrospinal fluid (aCSF) 
containing: NaCl 119 mM; KC12.5 mM; MgS04 1.3 mM; CaCl2 2.5 mM; 
NaHC03 26.2 mM; NaH2P04 1 mM; glucose 11 mM (300 mOsm, pH 
7.4). Patch-clamp recording pipette tip resistances were 3.5-5 MO 
when filled with solution containing K-gluconate 122.5 mM; KCI 
17.5 mM; NaCl 8 mM; KOH-HEPES 10 mM; KOH-EGTA 0.2 mM; 
MgATP 2 mM; and Na3GTP 0.3 mM (295 mOsm, pH 7.2). Resting 
membrane potential was measured in current clamp mode at 0 pA. 
Input resistance was assessed from 5 mV square voltage pulses at 
RMP. For 1/V curves, we measured the membrane potential, while 
injecting 500 ms positive or negative currents stepwise (Figs. 1M, N). 
Whole-cell currents and voltages were amplified by a patch-clamp 
amplifier (EPC10; HEKA Elektronik). 
All data are presented as mean ± standard error of the mean 
(SEM). Comparisons of parameters within the cell lines were done by 
Student's t-test, and analysis for temporal changes within the cell 
lines by linear regression. Level of significance was set at p<0.05. 
Expression of the neuronal marker (3-III-tubulin and the dopami-
nergic marker TH reached maximum after 12 days under differenti-
ation conditions, and was observed in 19.7 ±1.6% and 12.1 ±1.0% of 
the total number of cells, respectively. The GFAP± glial cell population 
at this stage of differentiation constituted 2.9 ±0.3% of all cells 
(Supplementary figure 1A-C). After 30 days of differentiation, the 
percentage of TH-expressing cells decreased compared to 12 days to 
7.4 ±0.4%, while the percentage of GFAP± cells increased to 5.6 ± 
0.4%. The fraction of (3-III-tubulin expressing cells remained stable at 
30 days (21.2 ±1.7% of the total population) and did not differ from 
that at 12 days (Figs. 1A-C). 
After 12 days of differentiation, application of 60 mM potassium 
increased intracellular calcium in 9.5 ±2.4 % of cells (Supplementary 
figure 1D-F). Application of 100 uM dopamine elicited a calcium 
increase in 8.8 ± 1.9% of cells, while 9.6 ± 2.7% and 7.3 ± 1.7% of cells 
responded to 100 uM glutamate and 100 uM GABA, respectively (Figs. 
1D-L), already after 7 days of differentiation. Glutamate responses 
were blocked by the NMDA receptor antagonist MK-801, and GABA 
responses by the GABAA receptor antagonist PTX (Figs. ID, J), 
confirming receptor specificity. 
Using whole-cell patch-clamp recordings at later stages of 
differentiation (between 20 and 32 days), we found that 37 out of 54 
recorded cells (68%) displayed active membrane properties suggestive 
of an immature neuronal phenotype (Fig. IN). Sixteen cells (43%) fired 
immature action potentials upon current injections. Over the 
differentiation period, there was a significant decrease in resting 
membrane potential (RMP) assessed as linear regression and with t-
test, from-65.4 ±4.5 mV at days 20-21 (n = 8) to -41.6 ±7.3 mVat 
day 32 (n = 9; Figs. 1Q, R). This was not accompanied by significant 
changes in input resistance (R¡) (assessed by linear regression and t-
test), the average value at days 20-21 being 2029 ± 353 (n = 8) and at 
day 32 being 3003 ±425 (n = 8; Fig. IT). We further compared the 
current-voltage {¡-V) relationship of the recorded cells at days 20-23 
with those at days 31-32. There was clearly less inward rectification 
during application of hyper- and depolarizing pulses to the membrane 
in the cells at days 31-32 of differentiation, as compared to days 20-22 
(Fig. 1R). Among 16 cells exhibiting passive membrane properties 
(Fig. 1M), we observed a significant decrease in RMP, from — 86.4± 
0.76 mV at days 20-22 (n= 10) to -75.8 ±3.7 mV at days 29-32 
(n = 4; Fig. IP). The R¡ was unaltered in these cells over time, being 
69.6± 14.6 MÜ at days 20-22 (n = 10) and 75.4± 19.0 Mil at days 29-
32 (n = 4, Fig. IS). The nominally high resting membrane potential, the 
lack of rectification and the low R¡ indicate that these cells have 
acquired glial-like properties. 
The hVMl cell line is able to survive in differentiation medium for 
more than 30 days, and from days 20-32 of differentiation more than 
half of the cells expressed neuronal electrophysiological properties, 
including membrane rectification and immature action potential firing. 
In one cell, we observed spontaneous action potentials that increased in 
frequency upon current injection-induced depolarization. These find-
ings provide evidence that expanded immortalized human fetal neural 
stem cells sustain their molecular identity to acquire neuronal 
properties, and that differentiation can be achieved in vitro. It should 
Fig. 1. Immunocytochemical analysis after 12 days of differentiation revealed 5.6 ±0.4% GFAP positive cells (A), 21.2 ±1.7% (J-III-tubulin expressing cells (B) and 7.4 ±0.4 %TH 
positive cells (C). Calcium imaging confirmed that the hVMl cell could respond to bolus application of Glutamate (D-F), dopamine (DA) (G-I) and GABA (J-L), and that the response to 
glutamate could be blocked by the NMDA receptor antagonist MK-801 (D), while the GABA response was blocked by the GABAfl antagonist PTX (J). Electrophysiological patch-clamp 
recordings confirmed neuronal and glial subpopulations of cells, that could be discriminated based on passive membrane properties in the glial fraction (M, O) and active properties, 
including rectification and action potential firing, in the neuronal fraction (N, O). Among both neuronal and glial cells there was a decrease in the resting membrane potential over the 
recording period, covering days 19-31 of differentiation (P, Q). The input resistance of the cells did not change over this period (S, T). Loss of membrane rectification over time (R), 
together with decrease in membrane potential, in the neural population, indicates compromised cell membrane. Scale bar in D, G, J: 2 min; in A and K: 20 |jm. *p<0.05. 
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Calcium imaging 
be noted, though, that we did not observe post-synaptic currents in any 
of the recorded cells under the present conditions, indicating that no 
functional synaptic connections between cells had been established. 
Our finding that maximum expression of (3-III-tubulin occurs after 
12 days and is unchanged after 30 days of differentiation corroborates 
the original report describing the immunocytochemical properties of 
the hVMl cell line (Villa et al., 2009). In this previous report we 
additionally confirmed expression of an array of midbrain dopami-
nergic markers, including GIRK2, Calretinin, DAT, VMAT2, ADH2, 
Lmxla, Lmxlb, Pitx3, Nurr-1, Enl, Mashl and Ngn2, pointing to a 
substantia nigral profile of these cells (Villa et al., 2009). 
Over the reported time period, we observed a relative increase in 
GFAP-expressing glial cells and decrease in the fraction of TH-
expressing cells. These data indicate a loss of TH-expressing 
catecholaminergic neurons and possibly also other mature neurons, 
concomitant with the increase in the glial population. The decline in 
percentage of neurons was also suggested by the electrophysiological 
data, showing a reduction of RMP among both neuronal and passive 
cells over time, accompanied by a decrease in inward rectification in 
the neuronal population, indicating a compromised cell membrane. 
The gradual loss of membrane integrity likely reflects shortcomings in 
the in vitro culturing conditions. 
More than half of the recorded cells expressed immature 
neuronal properties. This neuronal fraction is substantially higher 
than that estimated based on the presented immunocytochemical 
data (20% of cells express (3-III-tubulin), and from calcium imaging 
data (7-10% of cells respond to glutamate, dopamine or GABA). This 
discrepancy could be due to bias in visually choosing cells with more 
neuronal appearance for patch-clamp recordings. However, it could 
also reflect higher sensitivity of the electrophysiological approach, 
compared to immunocytochemistry, as a method for evaluating 
neuronal differentiation. 
We found that GABA application, similar to glutamate, induced 
calcium inflow into the cells. Normally, GABA hyperpolarizes neurons, 
driving the membrane potential away from what would activate 
voltage-dependent calcium channels (Rabow et al., 1995). However, 
in immature neurons, GABA acts as depolarizing transmitter due to 
higher chloride concentration inside the cells as compared to outside 
(Cherubini et al., 1991; Rivera et al., 1999). This was apparently the 
case in our experiments with calcium imaging. 
Dopamine can depolarize or hyperpolarize neurons through Dl 
and D2 metabotrobic receptors, respectively. The D2 receptors are 
expressed on nigral dopaminergic neurons mediating autoinhibition 
(Lacey et al., 1989). Recent experiments have demonstrated D2 
autoreceptor activation induces intracellular calcium release in 
human embryonic stem cell-derived dopaminergic neurons at all 
stages of maturation (Malmersjo et al., 2009). Therefore, it is likely 
that the observed increase in intra-cellular calcium of hVMl cells in 
response to dopamine application is a D2-mediated response in 
dopaminergic neurons. Alternatively, it can be a Dl receptor mediated 
response in non-dopaminergic neurons, expressing Dl receptors. 
Further studies are needed to elucidate the expression and function of 
dopamine receptor subtypes in hVMl cells. 
The hVMl cell line may become useful for generating dopaminer-
gic, and possibly other types of neurons, for experimental cell therapy 
approaches. It should be pointed out, though, that v-myc immortal-
ization of these cells is compromising with respect to their potential 
clinical applications (Nilsson and Cleveland, 2003). Our data provide 
evidence that the multipotent hVMl human ventral mesencephalic 
stem cell line is capable of differentiating into functional neurons, 
although under the present in vitro conditions with relatively 
immature properties. It was not possible to retrospectively identify 
recorded cells as dopaminergic under the current conditions. 
However, our previous immunocytochemical data show that 47% of 
(3-III-tubulin expressing cells were TH-positive, i.e., presumably 
dopaminergic (Villa et al., 2009). Therefore, it is reasonable to suggest 
that a considerable fraction of the recorded cells with immature 
neuronal properties were dopaminergic. Future in vivo studies, 
enabling longer survival times, and the development of human 
dopaminergic reporter constructs, e.g. human-TH-GFP, will shed light 
on the question whether these cells can differentiate to fully mature 
and functional ventral mesencephalic dopaminergic neurons. 
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Appendix A. Supplementary data 
Supplementary data associated with this article can be found, in 
the online version, at doi:10.1016/j.expneurol.2010.01.013. 
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